-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
G1 Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2023.
- G1 Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.09M, a 45.1% decline year-over-year.
- G1 Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $11.5M, a 31.7% decline year-over-year.
- G1 Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14.5M, a 29.5% decline from 2022.
- G1 Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $20.6M, a 7.75% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)